Delhi High Court refuses to direct Zydus to disclose manufacturing process of Sigrima: Gireesh Babu, New Delhi Saturday, July 26, 2025, 08:00 Hrs [IST] The Delhi High Court has sa ...

Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

The India-UK free trade agreement does not dilute New Delhi’s right to issue compulsory licences (CLs) and does not introduce any new preconditions for their issuance, an official said on Friday. The ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

An investigation can reveal the secret history of one of Australia’s top scientists, whose faked data underpins a drug now ...

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

An official clarified that the India-UK free trade agreement doesn't weaken India's power to issue compulsory licenses or add new requirements. The government retains full authority under existing law ...

A research team led by the University of California, Berkeley, has developed an innovative AI-powered framework that efficiently designs 3D truss metamaterials — structures known for their exceptional ...

During a live event, Mark Yarchoan, MD, and participants reviewed adverse event management for 3 different combination ...

The appeal of a drug-patent dispute that allowed patent owner Alkermes PLC to keep $65.6 million in allegedly improper ...